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Abstract
The evolution of antimicrobial resistance can be strongly affected by variations of antimicrobial concentration. Here,
we study the impact of periodic alternations of absence and presence of antimicrobial on resistance evolution in a
microbial population, using a stochastic model that includes variations of both population composition and size,
and fully incorporates stochastic population extinctions. We show that fast alternations of presence and absence of
antimicrobial are inefficient to eradicate the microbial population and strongly favor the establishment of resistance,
unless the antimicrobial increases enough the death rate. We further demonstrate that if the period of alternations
is longer than a threshold value, the microbial population goes extinct upon the first addition of antimicrobial, if it
is not rescued by resistance. We express the probability that the population is eradicated upon the first addition
of antimicrobial, assuming rare mutations. Rescue by resistance can happen either if resistant mutants preexist, or
if they appear after antimicrobial is added to the environment. Importantly, the latter case is fully prevented by
perfect biostatic antimicrobials that completely stop division of sensitive microorganisms. By contrast, we show
that the parameter regime where treatment is efficient is larger for biocidal drugs than for biostatic drugs. This
sheds light on the respective merits of different antimicrobial modes of action.
Introduction
Antibiotics and antivirals allow many major infectious diseases to be treated. However, with the increasing use
of antimicrobials, pathogenic microorganisms tend to become resistant to these drugs, which then become useless.
Understanding the evolution of resistance is of paramount importance in order to fight the major public health
issue raised by antimicrobial resistance [1, 2].
The evolution of antimicrobial resistance often occurs in a variable environment, as antimicrobial is added and
removed from a medium or given periodically to a patient [3, 4]. This results into varying patterns of selection,
which are known to have a dramatic effect on evolution in other contexts [5–9]. To address how variations of
antimicrobial concentration impact resistance evolution, we investigate theoretically the de novo acquisition of
resistance in a microbial population in the presence of alternations of phases of presence and absence of antimicrobial.
This situation can represent, for example, a treatment where the concentration within the patient falls under the
Minimum Inhibitory Concentration (MIC) between drug intakes [10], which is a realistic case [10, 11].
We propose a general stochastic model that incorporates variations of both population composition and size,
i.e. population genetics and population dynamics. Despite having a common origin in stochastic birth, death
and mutation events, and thus being intrinsically coupled, these phenomena are seldom considered together in
theoretical studies [12]. However, it is particularly crucial to address both of them when studying the evolution
of antimicrobial resistance, because the aim of an antimicrobial treatment is to eradicate a microbial population,
or at least to substantially decrease its size, while the evolution of resistance corresponds to a change in the
genetic makeup of the population. Our general model allows us to fully incorporate the stochasticity of mutation
occurrence and establishment [13–17], as well as that of population extinction, whose practical importance was
recently highlighted [18–20].
In this framework, we ask whether a microbial population subject to alternations of phases of presence and
absence of antimicrobial develops resistance, which corresponds to treatment failure and to rescue of the microbial
population by resistance [21, 22], or goes extinct, which corresponds to treatment success. In other words, we ask
whether the microbial population resists or perishes.
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We study both the impact of biocidal drugs, that kill microorganisms, and of biostatic drugs, that prevent
microorganisms from growing. We show that fast alternations of phases with and without antimicrobial do not
permit eradication of the microbial population before resistant mutants fix, unless the death rate with antimicrobial
is large enough. Conversely, intermediate alternation speeds are effective for a wider range of antimicrobial modes
of action, but the probability of population extinction and therefore of treatment success, which we fully quantify, is
not one, because resistance can rescue the population, and this effect depends on the size of the microbial population.
We find that the parameter range where antimicrobial treatment is efficient is larger for biocidal drugs than for
biostatic drugs. However, we also show that biocidal and imperfect biostatic antimicrobials permit an additional
mechanism of rescue by resistance compared to biostatic drugs that completely stop growth. This sheds light on the
respective merits of different antimicrobial modes of action. Finally, we find a population size-dependent critical
drug concentration below which antimicrobials cannot eradicate microbial populations.
Model and methods
We consider a microbial population with carrying capacity K, corresponding to the maximum population size that
the environment can sustain, given the nutrients available. The division rate of each microorganism is assumed
to be logistic, and reads f(1 − N/K), where N represents the total population size, while the fitness f is the
maximal division rate of the microorganism, reached when N ≪ K. This model therefore incorporates population
size variations, and allows us to include extinctions induced by the antimicrobial drug.
Mutations that confer antimicrobial resistance are often associated with a fitness cost, i.e. a slower reproduc-
tion [23–25], but this fitness cost can be compensated by subsequent mutations [26–29]. The acquisition of resistance
is therefore often irreversible, even if the antimicrobial is removed from the environment [24, 26]. Thus motivated,
we consider three types of microorganisms: sensitive (S) microorganisms, whose division or death rate is affected
by antimicrobials, resistant (R) microorganisms, that are not affected by antimicrobials but that bear a fitness cost,
and resistant-compensated (C) microorganisms that are not affected by antimicrobials and do not bear a fitness cost.
In the absence of antimicrobial, their fitnesses (maximal division rates) are denoted by fS , fR and fC , respectively,
and their death rates by gS, gR and gC . Values in the presence of antimicrobial are denoted by a prime, e.g. f
′
S .
Note that we include small but nonzero baseline death rates, which can model losses or the impact of the immune
system in vivo, and allows for population evolution even at steady-state size. Without loss of generality, we set
fS = 1 throughout. In other words, the maximum reproduction rate of S microorganisms, attained when population
size is much smaller than the carrying capacity, sets our time unit. We further denote by µ1 and µ2 the mutation
probabilities upon each division for the mutation from S to R and from R to C, respectively. In several actual cases,
the effective mutation rate towards compensation is higher than the one towards the return to sensitivity, because
multiple mutations can compensate for the initial cost of resistance [27, 28, 30]. Thus, we do not take into account
back-mutations. Still because of the abundance of possible compensatory mutations, often µ1 ≪ µ2 [27, 31]. We
provide general analytical results as a function of µ1 and µ2, and we focus more on the limit µ1 ≪ µ2, especially in
simulations.
Our model thus incorporates both population dynamics and population genetics [7,12,32], and is more realistic
than descriptions assuming constant population sizes [33], e.g. in the framework of the Moran process [13, 34].
Throughout, our time unit corresponds to a generation of sensitive microorganisms without antimicrobial in the
exponential phase (reached when N ≪ K).
The action of an antimicrobial drug can be quantified by its MIC, which corresponds the minimum concentration
that stops the growth of a microbial population [24]. More precisely, the MIC corresponds to the concentration
such that death rate and division rate are equal [18]: in a deterministic framework, above the MIC, the population
goes extinct, while below it, it grows until reaching carrying capacity. We investigate the impact of periodic
alternations of phases of absence and presence of antimicrobial, at concentrations both above and below the MIC.
We consider both biostatic antimicrobials, which decrease the division rate of microorganisms (f ′S < fS), and
biocidal antimicrobials, which increase the death rate of microorganisms (g′S > gS) [18].
We start from a microbial population where all individuals are S (sensitive), without antimicrobial. Specifically,
we generally start our simulations with 10 S microorganisms, thus including a phase of initial growth, which can
model the development of an infection starting from the bottleneck at transmission [35]. Our results are robust to
variations of this initial condition, since we mainly consider timescales longer than that of the initial growth of the
population to its equilibrium size. Note however that if we started with a very small number of S microorganisms
(i.e. 1 or 2), we would need to take into account rapid stochastic extinctions (see Fig. S3B).
Antimicrobial both drives the decrease of the population of sensitive microorganisms and selects for resistance.
We ask whether resistance fully evolves de novo, leading to the C microorganisms taking over, or whether the
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microbial population goes extinct before this happens. The first case corresponds to treatment failure, and the
second to treatment success. Hence, we are interested in the probability p0 of extinction of the microbial population
before C microorganisms fix in the population, i.e. take over. We also discuss the average time tfix it takes for the
population to fully evolve resistance, up to full fixation of the C microorganisms, and the mean time to extinction
before the fixation of the C type text.
We present both analytical and numerical results. Our analytical results are obtained using methods from
stochastic processes, including the Moran process at fixed population size [13] and birth-death processes with time
varying rates [36–39]. Our simulations employ a Gillespie algorithm [40,41], and incorporate all individual stochastic
division, mutation and death events with their exact rates (see Supporting Information, section 5 for details).
Results
Conditions for a periodic presence of perfect biostatic antimicrobial to eradicate the
microbial population
Do periodic alternations of phases with and without antimicrobial allow the eradication of a microbial population,
or does resistance develop? We first address this question in the case of a biostatic antimicrobial sufficiently above
the MIC to completely stop the growth of S microorganisms. With such a “perfect” biostatic antimicrobial, the
fitness of S microorganisms is f ′S = 0, while without antimicrobial, fS = 1. Here, we assume that the death rate of
S microorganisms is not affected by the antimicrobial, i.e. g′S = gS , but the case of a biocidal antimicrobial will be
considered next.
A crucial point is how the duration of a phase with antimicrobial, which corresponds here to the half-period
T/2 of alternations, compares to the average time τS needed for a population of S microorganisms to go extinct
in the presence of antimicrobial. Indeed, if T/2 ≫ τS , one single phase with antimicrobial suffices to eradicate a
microbial population in the absence of resistance. An exact first passage time calculation [33, 42] (see Supporting
Information, section 1.2, Eq. S7) yields τS = (1/gS)×
∑N
i=1(1/i) ≈ log(N)/gS , where N ≫ 1 represents the number
of microorganisms when antimicrobial is first added, i.e. at T/2. If the phase before antimicrobial is added is much
longer than the initial growth timescale of the population, i.e. if T/2 ≫ 1/(fS − gS) (see Supporting Information,
section 1.3.1), N can be taken equal to the deterministic equilibrium population size N = K(1−gS/fS), obtained by
setting the birth rate fS(1−N/K) equal to the death rate gS. Hence, τS ≈ log [K(1− gS/fS)] /gS. Our simulation
results in Fig. 1A display an abrupt increase in the probability p0 that the microbial population goes extinct before
developing resistance for T = 2τS , in good agreement with our analytical prediction.
For fast alternations satisfying T/2 ≪ τS , the phases with antimicrobial are not long enough to eradicate the
microbial population, yielding a systematic evolution of resistance, and thus a vanishing probability p0 of extinction
before resistance takes over. This prediction is confirmed by our simulation results in Fig. 1A, and an example of
resistance evolution in this regime is shown in Fig. 1B. In the limit of very fast alternations, we expect an effective
averaging of the fitness of S microorganisms, with f˜S = 0.5. Thus, an R mutant whose lineage will take over the
population (i.e. fix) appears after an average time t˜aR = 1/(N˜µ1gS p˜SR) where N˜µ1gS represents the total mutation
rate in the population, with N˜ = K(1 − gS/f˜S), and where p˜SR = (1 − f˜S/fR)/[1 − (f˜S/fR)N˜ ] is the probability
that a single R mutant fixes in a population of S microorganisms with constant size N˜ , calculated within the
Moran model [13]. Subsequently, C mutants will appear and fix, thus leading to the full evolution of resistance in
the population. The corresponding average total time tfix of resistance evolution [33] obtained in our simulations
agrees well with the analytical expression of t˜aR for T/2≪ τS (see Fig. S4C).
Conversely, if T/2≫ τS , the microbial population is eradicated by the first phase with antimicrobial, provided
that no resistant mutant preexists when antimicrobial is added to the environment. Indeed, resistance cannot
appear in the presence of a perfect biostatic antimicrobial since S microorganisms then cannot divide. Thus, in
the absence of existing R mutants, extinction occurs shortly after time T/2 (see Fig. S4B), and the situation is
equivalent to adding antimicrobial at T/2 and leaving it thereafter, as exemplified by Fig. 1C. Note that although
unlikely, fixation of resistance in the absence of antimicrobial will end up happening by spontaneous fitness valley
crossing if the first phase without antimicrobial is long enough. Specifically, this will occur if T/2 ≫ τV , where
τV ≈ (fS − fR)/(µ1µ2gS) is the average valley crossing time by tunneling, which is the relevant process unless
populations are very small [17, 33, 43, 44]. Accordingly, our simulation results in Fig. S4, which includes longer
alternation periods than Fig. 1, feature three distinct regimes, and vanishing extinction probabilities are obtained
for T/2≫ τV , as well as for T/2≪ τS .
Let us now focus on the regime where antimicrobial treatment can induce extinction of the microbial population,
namely τS ≪ T/2 ≪ τV , and calculate the extinction probability p0. A necessary condition for the population to
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Fig 1. Periodic presence of a perfect biostatic antimicrobial. A: Probability p0 that the microbial
population goes extinct before resistance gets established versus alternation period T , for various carrying
capacities K. Markers: simulation results, with probabilities estimated over 102 − 103 realizations. Horizontal
solid lines: analytical predictions from Eq. 1. Dashed lines: T/2 = τS . B and C: Numbers of sensitive (S),
resistant (R) and compensated (C) microorganisms versus time in example simulation runs for K = 1000, with
T = 20 and T = 1000 respectively. In B, resistance takes over, while in C, extinction occurs shortly after
antimicrobial is first added. Phases without (resp. with) antimicrobial are shaded in white (resp. gray).
Parameter values: fS = 1 without antimicrobial, f
′
S = 0 with antimicrobial, fR = 0.9, fC = 1, gS = gR = gC = 0.1,
µ1 = 10
−5 and µ2 = 10
−3. All simulations start with 10 S microorganisms.
be rescued by resistance [21] and avoid extinction is that at least one R mutant be present when antimicrobial
is added. In the rare mutation regime Kµ1 ≪ 1, this occurs with probability pR = t
app
R /τ
d
R = Nµ1gSτ
d
R, where
tappR = 1/(Nµ1gS) is the average time of appearance of a resistant mutant, while τ
d
R is the average lifetime of a
resistant lineage (destined for extinction without antimicrobial), both calculated in a population of S individuals
with fixed size N = K(1 − gS/fS) [13, 33]. Importantly, the presence of R mutants does not guarantee the rescue
of the microbial population, because small subpopulations of R microorganisms may undergo a rapid stochastic
extinction. The probability peR(i) of such an extinction event depends on the number of R microorganisms present
when antimicrobial is added, which is i with a probability denoted by pcR(i). The probability p0 that the microbial
population is not rescued by resistance and goes extinct can then be expressed as:
p0 = 1− pR
N−1∑
i=1
pcR(i)(1− p
e
R(i)) . (1)
The probability pcR(i) can be calculated within the Moran model since the population size is stable around N =
K(1 − gS/fS) before antimicrobial is added. Specifically, it can be expressed as the ratio of the average time τdR,i
the lineage spends in the state where i mutants exist to the total lifetime τdR of the lineage without antimicrobial:
pcR(i) = τ
d
R,i/τ
d
R (see Supporting Information, section 3.1). Next, in order to calculate the probability p
e
R(i) that
the lineage of R mutants then quickly goes extinct, we approximate the reproduction rate of the R microorganisms
by fR(1 − (S(t) + R(t))/K) ≈ fR(1 − S(t)/K), where S(t) and R(t) are the numbers of S and R individuals
at time t. Indeed, early extinctions of R mutants tend to happen shortly after the addition of antimicrobials,
when S(t) ≫ R(t). Thus motivated, we further take the deterministic approximation S(t) = K(1 − gS/fS)e−gSt,
while retaining a stochastic description for the R mutants [36, 37]. We then employ the probability generating
function φi(z, t) =
∑
∞
j=0 z
jP (j, t|i, 0), where i is the initial number of R microorganisms, which satisfies peR(i) =
limt→∞ P (0, t|i, 0) = limt→∞ φi(0, t). Solving the partial differential equation governing the evolution of φi(z, t)
(see Supporting Information, section 3.2) yields [38, 39]
peR(i) = lim
t→∞
[
gR
∫ t
0 e
ρ(u)du
1 + gR
∫ t
0 e
ρ(u)du
]i
, (2)
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with
ρ(t) =
∫ t
0
[
gR − fR
(
1−
S(u)
K
)]
du . (3)
Eq. 1 then allows us to predict the probability that the microbial population goes extinct thanks to the first addition
of antimicrobial. Fig. 1A demonstrates a very good agreement between this analytical prediction and our simulation
results in the rare mutation regime Kµ1 ≪ 1, and Fig. S7 further demonstrates good agreement for each separate
term of Eq. 1 in this regime. For larger populations, the probability that the microbial population is rescued
by resistance increases, and the extinction probability tends to zero for frequent mutations Kµ1 ≫ 1 because R
mutants are then always present in the population, in numbers that essentially ensure their survival (see Fig. 1A).
Biocidal antimicrobials and imperfect biostatic ones allow an extra mechanism of
rescue by resistance
How does the mode of action of the antimicrobial impact our results? So far, we considered a perfect biostatic
antimicrobial that stops the growth of sensitive microorganisms but does not affect their death rate. Let us now
turn to the general case of an antimicrobial that can affect both the division rate and the death rate of sensitive
microorganisms, and let us assume that we are above the MIC, i.e. g′S > f
′
S. In this section, we present general
calculations, but focus most of our discussion on purely biocidal antimicrobials, which increase the death rate of
sensitive microorganisms without affecting their growth rate, and compare them to purely biostatic antimicrobials.
Again, a crucial point is how the duration T/2 of a phase with antimicrobial compares to the average time τS
needed for a population of S microorganisms to go extinct in the presence of antimicrobial (see Eq. S6). Indeed, our
simulation results in Figs. 2A and 2D display an abrupt change in the probability that the microbial population
goes extinct before developing resistance for T = 2τS .
For small periods T/2 ≪ τS , one phase with antimicrobial is not long enough to eradicate the microbial
population. However, the alternations may induce an overall decrease in the population over multiple periods, then
leading to extinction. This is the case when the deterministic growth timescale 1/(fS − gS) is larger than the
decay timescale 1/(g′S − f
′
S). Equivalently, in the limit of very fast alternations, there is no nonzero stationary
population size when f˜S = (fS + f
′
S)/2 < g˜S = (gS + g
′
S)/2, yielding the same condition. For a biostatic drug
such that g′S = gS , this situation cannot happen if gS < fS/2, which is realistic since baseline death rates are
usually small. Conversely, for a biocidal drug such that f ′S = fS , a systematic evolution of resistance will occur
if g′S < 2fS − gS , while population decay over several periods and extinction will occur if g
′
S > 2fS − gS . These
predictions are confirmed by the simulation results in Figs. 2A and D, respectively, and the two different cases
are exemplified in Figs. 2B and E. Both of these regimes can arise, depending on the concentration of biocidal
antimicrobial. Figs. 2A-C corresponds to concentrations just above the MIC, while Figs. 2D-F correspond to larger
concentrations of bactericidal drugs, which can induce death rates equal to several times the birth rate [45,46]. Note
that in Fig. 2A, the extinction probability is not zero for small periods with K = 102: this is because stochastic
extinctions can occur before resistance takes over for such a small equilibrium population size.
For slower alternations satisfying T/2 ≫ τS , the microbial population is eradicated by the first phase with an-
timicrobial, unless resistance rescues it. Extinction then occurs shortly after time T/2 (see Fig. S5B and examples
in Fig. 2C and F). Importantly, with a biocidal antimicrobial or with an imperfect biostatic one, the microbial popu-
lation can be rescued by resistance in two different ways: either if resistant bacteria are present when antimicrobial
is added, or if they appear afterwards. This second case is exemplified in Fig. 3. It can happen because even at high
concentration, such antimicrobials do not prevent S microorganisms from dividing, contrarily to a perfect biostatic
one. Because of this, rescue by resistance can become more likely than with perfect biostatic antimicrobials. Note
that, as in the perfect biostatic case, the spontaneous fixation of resistant mutants without antimicrobial will occur
if T/2≫ τV ≈ (fS − fR)/(µ1µ2gS) (see Fig. S5).
Let us focus on the regime where the treatment can efficiently induce extinction, namely τS ≪ T/2≪ τV . The
probability p0 that the microbial population is not rescued by resistance and goes extinct can then be expressed as:
p0 =
[
1− pR
N−1∑
i=1
pcR(i)(1 − p
e
R(i))
] [
1− paR(1 − p
e′
R)
]
. (4)
Apart from the last term, which corresponds to resistance appearing after antimicrobial is first added, Eq. 4 is
identical to Eq. 1. The quantities pR and p
c
R(i) are the same as in that case, since they only depend on what
happens just before antimicrobial is added. While peR(i) is conceptually similar to the perfect biostatic case, it
depends on f ′S and g
′
S , and its general calculation is presented in Section 3.2 of the Supporting Information. This
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Fig 2. Periodic presence of a biocidal antimicrobial above the MIC. A: Probability p0 that the
microbial population goes extinct before resistance gets established versus alternation period T , for various
carrying capacities K. Markers: simulation results, with probabilities estimated over 102 − 103 realizations.
Horizontal solid lines: analytical predictions from Eq. 4. Dashed lines: T/2 = τS . B and C: Numbers of sensitive
(S), resistant (R) and compensated (C) microorganisms versus time in example simulation runs for K = 1000,
with T = 8 and T = 1000 respectively. In B, resistance takes over, while in C, extinction occurs shortly after
antimicrobial is first added. Phases without (resp. with) antimicrobial are shaded in white (resp. gray).
Parameter values in A, B and C: fS = 1, fR = 0.9, fC = 1, gS = 0.1 without antimicrobial, g
′
S = 1.1 with
antimicrobial, gR = gC = 0.1, µ1 = 10
−5 and µ2 = 10
−3. All simulations start with 10 S microorganisms. D, E
and F: same as A, B and C, but with g′S = 2. All other parameters are the same.
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Fig 3. Resistance emergence in the presence of a biocidal antimicrobial above the MIC. A: Numbers
of sensitive (S), resistant (R) and compensated (C) microorganisms versus time in an example simulation run for
K = 104, with T = 1000. Here resistance takes over. Phases without (resp. with) antimicrobial are shaded in
white (resp. gray). B: Zoom showing the emergence of resistance in this realization: an R mutant appears after
antimicrobial is added (gray). At this time, the S population is decreasing due to the antimicrobial-induced high
death rate, but the surviving S microorganisms are still able to divide. Parameter values and initial conditions are
the same as in Fig. 2A, B and C.
leaves us with the new case where resistance appears in the presence of antimicrobial. In the rare mutation regime
such that Ndivµ1 ≪ 1, it happens with probability paR = Ndivµ1, where
Ndiv =
∫ τS
0
fS
(
1−
S(t)
K
)
S(t) dt (5)
is the number of divisions that would occur in a population of S microorganisms between the addition of antimicrobial
(taken as the origin of time here) and extinction. Employing the deterministic approximation for the number S(t)
of S microorganisms (see Eq. S21), the probability that the lineage of an R mutant that appears at time t0 quickly
goes extinct can be obtained in a similar way as for Eq. 2, yielding
pe
′
R(t0) = lim
t→∞
gR
∫ t
t0
eη(u)du
1 + gR
∫ t
t0
eη(u)du
, (6)
with
η(t) =
∫ t
t0
[
gR − fR
(
1−
S(u)
K
)]
du . (7)
We then estimate the probability pe
′
R that the lineage of an R mutant that appears after the addition of antimicrobial
quickly goes extinct by averaging pe
′
R(t0) over the time t0 of appearance of the mutant, under the assumption that
exactly one R mutant appears:
pe
′
R =
∫
∞
0
pe
′
R(t0) ℘
a
R(t0) dt0 , (8)
with
℘aR(t0) =
S(t0)
(
1− S(t0)
K
)
∫
∞
0
S(t)
(
1− S(t)
K
)
dt
. (9)
Eq. 4 then yields the probability that the microbial population goes extinct thanks to the first addition of antimi-
crobial. Fig. 2A demonstrates a very good agreement between this analytical prediction and our simulation results
in the rare mutation regime Kµ1 ≪ 1, and Figs. S7A-B, S8 and S9 further demonstrate good agreement for each
term involved in Eq. 4 in this regime.
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Fig 4. Dependence of the extinction probability p0 on population size and antimicrobial mode of
action. The extinction probability p0 is plotted versus carrying capacity K for the perfect biostatic drug
(corresponding to Fig. 1) and two different concentrations of biocidal drugs yielding two different death rates g′S
(corresponding to Fig. 2). Markers correspond to simulation results, computed over 103 realizations. Solid lines
correspond to our analytical predictions from Eqs. 1 and 4, respectively, which hold for K ≪ 1/µ1. Parameter
values and initial conditions are the same as in Figs. 1 and 2, respectively, and the period of alternations is
T = 103, which is in the large-period regime.
The extinction probability p0 depends on the size of the microbial population through its carrying capacity K
and on the division and death rates with antimicrobial. Fig. 4 shows the decrease of p0 with K, with p0 reaching
0 for Kµ1 ≫ 1 since resistant mutants are then always present when antimicrobial is added. Moreover, Fig. 4
shows that p0 depends on the antimicrobial mode of action, with large death rates favoring larger p0 in the biocidal
case, and with the perfect biostatic antimicrobial yielding the largest p0. Qualitatively, the observed increase of
p0 as g
′
S increases with a biocidal drug mainly arises from the faster decay of the population of S microorganisms,
which reduces the probability paR that an R mutant appears in the presence of antimicrobial. Furthermore, one
can show that the extinction probability p0 is larger for a perfect biostatic antimicrobial than for a perfect biocidal
antimicrobial with g′S → ∞ (see Supporting Information, Section 3.4). Indeed, S microorganisms survive longer
in the presence of a perfect biostatic drug, which reduces the division rate of the R mutants due to the logistic
growth term, and thus favors their extinction. Such a competition effect is realistic if S microorganisms still take
up resources (e.g. nutrients) even while they are not dividing.
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Sub-MIC drug concentrations and stochastic extinctions
So far, we considered antimicrobial drugs above the MIC, allowing deterministic extinction in the absence of
resistance for long enough drug exposure times. However, sub-MIC drugs can also have a major impact on the
evolution of resistance, by selecting for resistance without killing large microbial populations, and moreover by
facilitating stochastic extinctions in finite-sized microbial populations [18–20]. In the sub-MIC regime where f ′S > g
′
S ,
the population has a nonzero deterministic equilibrium size N ′ = K(1 − g′S/f
′
S) in the presence of antimicrobial.
Nevertheless, stochastic extinctions can remain relatively fast, especially in the weakly-sub-MIC regime where f ′S
is close to g′S, and if K is not very large. The key point is whether resistance appears before the extinction time
τS . The average time of appearance of an R mutant that fixes in a population of N
′ individuals in the presence
of sub-MIC antimicrobial is taR = 1/(N
′µ1g
′
Sp
′
SR), where p
′
SR = [1 − f
′
SgR/(fRg
′
S)]/[1 − (f
′
SgR/(fRg
′
S))
N ′ ] is the
fixation probability of an R mutant in a population of S individuals with fixed size N ′ (see Supporting Information,
Section 4, and Ref. [47]). Therefore, we expect resistance to take over and the extinction probability p0 to be very
small if taR ≪ τS below the MIC, even for large periods such that τS < T/2.
Fig. 5 shows heatmaps of the probability p0 that the microbial population goes extinct before resistance takes
over, in the cases of biostatic and biocidal drugs, plotted versus the period of alternations T and the non-dimensional
variable R = (g′S − f
′
S)/g
′
S , which increases with antimicrobial concentration and is zero at the minimum inhibitory
concentration (MIC). In both cases, two main regions are apparent, one with p0 = 0 and one where p0 is close to
one. The transition between them is well described by the solid line T/2 = τS such that the time spent with drug
is equal to the extinction time τS of a population of sensitive microbes with drug, except for large periods, where
the relevant transition occurs below the MIC (R < 0) and is given by taR = τS (dashed line), consistently with our
analytical predictions.
A B
P ability of extinction p Probability of extinction p
Fig 5. Heatmaps of the extinction probability. Extinction probability p0 versus alternation period T and
R = (g′S − f
′
S)/g
′
S with biostatic (A) or biocidal (B) antimicrobial. Heatmap: simulation data, each point
computed over 103 realizations of simulation results, and linearly interpolated. Dashed white line: value of R such
that taR = τS (see main text). Solid white line: T/2 = τS . Parameter values: K = 10
3, µ1 = 10
−5, µ2 = 10
−3,
fS = 1, fR = 0.9, fC = 1, gS = gR = gC = 0.1, and (A) g
′
S = 0.1 and variable f
′
S or (B) f
′
S = 1 and variable g
′
S .
Dotted line in B: R = (fS − gS)/(2fS − gS). All simulations start with 10 S microorganisms.
The ratio R enables us to make a quantitative comparison between biostatic and biocidal drugs. Let us focus
first on the transition τS = t
a
R. Eq. S6 shows that the average time it takes for the sensitive microorganisms to
spontaneously go extinct in the presence of antimicrobial can be written as τS(f
′
S , g
′
S) = Φ(R)/g
′
S , where Φ is a non-
dimensional function. Besides, the average fixation time of a R mutant in a population of S individuals can also be
expressed as taR(f
′
S , g
′
S) = Ψ(R)/g
′
S , where Ψ is a non-dimensional function. Thus, the transition τS = t
a
R will be the
same for biostatic and biocidal drugs at a given value ofR. Conversely, the transition τS = T/2, i.e. Φ(R)/g′S = T/2,
depends on g′S, and is thus different for biostatic and biocidal drugs at the same value of R. Specifically, for a given
value of R, smaller periods T will suffice to get extinction after the first addition of antimicrobial for a biocidal drug
than for a biostatic drug, because g′S is increased by biocidal drugs, and hence τS is smaller in the biocidal case than
in the biostatic case. This means that the parameter regime where treatment is efficient is larger for biocidal drugs
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than for biostatic drugs, as can be seen by comparing Fig. 5A and Fig. 5B. Significantly above the MIC, another
difference is that biocidal drugs become efficient even for short periods T/2 ≪ τS if their concentration is large
enough to have g′S > 2fS − gS , i.e. R > (fS − gS)/(2fS − gS) (see above, esp. Figs. 2D-E). Numerical simulation
results agree well with this prediction (dotted line on Fig. 5B).
Importantly, the transition between large and small extinction probability when R (and thus the antimicrobial
concentration) is varied strongly depends on population size (Figs. 6 and S6), and also depends on antimicrobial
mode of action (Fig. 6). For small periods where the relevant transition occurs for T/2 = τS , concentrations above
the MIC (R > 0) can actually be necessary to get extinction because one period may not suffice to get extinction,
and moreover, the extinction threshold value R is not the same for biostatic and biocidal antimicrobials (see above
and Figs. 6A-B). Conversely, for large periods where the relevant transition occurs for taR = τS , and extinction
occurs upon the first addition of drug, the extinction threshold is always below the MIC (R < 0) and it is the same
for biostatic and biocidal antimicrobials (see above and Fig. 6C). In both cases, the larger the population, the larger
the concentration required to get large extinction probabilities. For large periods (Fig. 6C), the transition occurs
close to the MIC for large populations, but the smaller the population, the larger the discrepancy between the MIC
and the actual transition, as predicted by our analytical estimate based on taR = τS (see Fig. S6). This is because
in small populations, stochastic extinctions of the population are quite fast at weakly sub-MIC antimicrobial. This
is a form of inoculum effect, where the effective MIC depends on the size of the bacterial population [20]. In the
large period regime (Fig. 6C), the extinction probability p0 is well-predicted by Eqs. 1 and 4 for the R values such
at most one R mutant can appear before the extinction of the population (as assumed in our calculation of paR).
In Figs. 6A-B, transitions between small and large values of p0 in simulated data are observed for smaller
threshold values of R than predicted by T/2 = τS (this can also be seen in Fig. 5, where the solid white line is
somewhat in the blue zone corresponding to large p0). This is because we have employed the average extinction
time τS , while extinction is a stochastic process. Thus, even if T/2 < τS , upon each addition of antimicrobial, there
is a nonzero probability that extinction actually occurs within the half-period. Denoting by p the probability that
a given extinction time is smaller than T/2, the population will on average go extinct after 1/p periods, unless
resistance fixes earlier. For instance, a population with carrying capacity K = 102 submitted to alternations with
T = 102.5 is predicted to develop resistance before extinction if R < 0.055. However, for R = −0.1, simulations
yield a probability p0 = 0.99 of extinction before resistance takes over (see Fig. 6A). In this case, simulations
yield p = 0.3, implying that extinction typically occurs in ∼3 periods, thus explaining the large value of p0. More
generally, the probability distribution function of the extinction time can depend on various parameters, which can
impact the discrepancy between the predicted and observed transitions. A more precise calculation would involve
this distribution. Note that the distribution of extinction times is known to be exponential for populations with a
quasi-stationary state [48, 49], but the present situation is more complex because there is no nonzero deterministic
equilibrium population size below the MIC, and because the population size at the time when antimicrobial is added
is far from the equilibrium value with antimicrobial. Nevertheless, our prediction based on the average extinction
time τS yields the right transition shape (see Fig. 5) and the correct expectations for T/2≫ τS and T/2≪ τS .
Discussion
The evolution of antimicrobial resistance often occurs in variable environments, as antimicrobial is added and
removed from a medium or given periodically to a patient, e.g. in a treatment by the oral route [3,4]. Alternations
of phases of absence and presence of antimicrobial induce a dramatic time variability of selection pressure on
microorganisms, and can thus have a strong impact on resistance evolution. Using a general stochastic model which
includes variations of both composition and size of the microbial population, we have shed light on the impact
of periodic alternations of presence and absence of antimicrobial on the probability that resistance evolves de
novo and rescues a microbial population from extinction. The majority of previous studies of periodic antimicrobial
treatments [10,50–55] neglect stochastic effects, while they can have a crucial evolutionary impact [13,15], especially
on population extinction [18,20]. In addition, established microbial populations are structured, even within a single
patient [56], and competition is local, which decreases their effective size, thus making stochasticity relevant. While
a few previous studies did take stochasticity into account, some did not include logistic growth or compensation of
the cost of resistance [36], while others made specific assumptions on treatments or epidemiology [57, 58], focused
on numerical results with few analytical predictions [59], or assumed a constant population size [33]. The present
model has the advantage of being quite general while fully accounting for stochasticity and finite-population effects.
We showed that fast alternations of presence and absence of antimicrobial are inefficient to eradicate the microbial
population and strongly favor the establishment of resistance, unless the antimicrobial increases enough the death
rate, which can occur for biocidal antimicrobials at high concentration [45, 46]. The corresponding criterion on
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Fig 6. Dependence of the extinction transition on population size and antimicrobial mode of action.
Extinction probability p0 versus the ratio R = (g′S − f
′
S)/g
′
S with biostatic or biocidal antimicrobial, for different
carrying capacities K, either in the small-period regime, with T = 102.5 (A and B) or in the large-period regime,
with T = 105 (C). Markers: simulation results, calculated over 103 realizations. Vertical dashed lines: predicted
extinction thresholds, i.e. values of R such that T/2 = τS (A and B) or taR = τS (C). Solid lines (C): Analytical
estimates of p0 from Eq. 1 (biostatic) or Eq. 4 (biocidal). For K = 10
2 and 103, the analytical predictions in the
biostatic and biocidal case are confounded, while for K = 104 we used two shades of green to show the slight
difference (light: biostatic, dark: biocidal). Parameter values: µ1 = 10
−5, µ2 = 10
−3, fS = 1, fR = 0.9, fC = 1,
gS = gR = gC = 0.1, and g
′
S = 0.1 (biostatic) or f
′
S = 1 (biocidal). All simulations start with 10 S microorganisms.
the death rate g′S of sensitive microorganisms with biocidal antimicrobial, namely g
′
S > 2fS − gS, is generally
more stringent than simply requiring drug concentrations to be above the MIC during the phases with biocidal
antimicrobial, namely g′S > fS . Indeed, the population can re-grow without antimicrobial: in this regime, extinction
occurs over multiple periods, and involves decaying oscillations. Conversely, for biostatic antimicrobials, as well as
for biocidal ones at smaller concentrations, extinction has to occur within a single phase with antimicrobial, and
thus the half-period T/2 has to be longer than the average extinction time τS , which we fully expressed analytically.
Importantly, shorter periods suffice for biocidal antimicrobials compared to biostatic ones in order to drive a
population to extinction upon the first addition of antimicrobial, at the same value of R = (g′S − f
′
S)/g
′
S. Hence,
the parameter regime where treatment is efficient is larger for biocidal drugs than for biostatic drugs. If T/2 > τS ,
the microbial population goes extinct upon the first addition of antimicrobial, unless it is rescued by resistance. We
obtained an analytical expression for the probability p0 that the population is eradicated upon the first addition of
antimicrobial, assuming rare mutations. Rescue by resistance can happen either if resistant mutants preexist upon
the addition of antimicrobial, or if they appear after antimicrobial is added to the environment, during the decay of
the population. Importantly, the latter case is fully prevented by perfect biostatic antimicrobials that completely
stop division of sensitive microorganisms. This sheds light on the respective merits of different antimicrobial modes
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of action. Finally, we showed that due to stochastic extinctions, sub-MIC concentrations of antimicrobials can
suffice to yield extinction of the population, and we fully quantified this effect and its dependence on population
size. Throughout, all of our analytical predictions were tested by numerical simulations, and the latter also allowed
us to explore cases beyond the rare mutation regime, where resistance occurs more frequently.
This work opens many possible theoretical extensions. In particular, it will be very interesting to include effects
such as antibiotic tolerance, which tend to precede resistance under intermittent antibiotic exposure [4], as well as to
consider the possibility of concentrations above the mutant prevention concentration, such that resistant microbes
are also affected by the drug [4, 54]. Another exciting extension would be to incorporate spatial structure [60–62]
and environment heterogeneity, in particular drug concentration gradients. Indeed, static gradients can strongly
accelerate resistance evolution [63–66], and one may ask how this effect combines with the temporal alternation-
driven one investigated here. Besides, it would be interesting to explicitly model horizontal gene transfer of resistance
mutations, to include realistic pharmacodynamics and pharmacokinetics [10], and also to compare the impact of
periodic alternations to that of random switches of the environment [5–9, 67–69].
Moreover, our results have consequences for actual experimental and clinical situations. First, several of our
predictions can be tested experimentally, in particular the transition of extinction probability between the small-
period and the large-period regimes, and the predicted values of this extinction probability for large periods. Second,
the situation where the phases of absence and presence of antimicrobial have similar durations, which we considered
here, is unfortunately clinically realistic. Indeed, a goal in treatment design is that the serum concentration of
antimicrobial exceeds the MIC for at least 40 to 50% of the time [11]. Because bacteria divide on a timescale
of about an hour in exponential growth phase, and because antimicrobial is often taken every 8 to 12 hours in
treatments by the oral route, the alternation period lasts for a few generations in treatments: this is the same
order of magnitude as the transition we found between the short-period and long-period regimes, meaning that this
transition is relevant in clinical cases. Therefore, it would be very interesting to conduct precise measurements of
both division rates and death rates [70] in actual infections in order to determine the relevant regime in each case.
This is all the more important that in the short-period regime, we showed that only large concentrations of biocidal
antimicrobials are efficient, while other antimicrobials systematically lead to the de novo evolution of resistance
before eradication of the microbial population. Conversely, a broader spectrum of modes of action can be successful
for longer periods of alternation of drug absence and presence. This constitutes a striking argument in favor of the
development of extended-release antimicrobial formulations [71].
Despite the fact that only biocidal antimicrobials at high concentration are efficient for short alternation periods
of absence and presence of drug, and the fact that the parameter regime where treatment is efficient is larger for
biocidal drugs than for biostatic drugs, biostatic antimicrobials that fully stop division of sensitive microorganisms
have a distinct advantage over drugs with other modes of action. Indeed, they prevent the emergence of resis-
tant mutants when drug is present, which is all the more important that such resistant mutants are immediately
selected for by the antimicrobial and are thus quite likely to rescue the microbial population and to lead to the
fixation of resistance. This argues in favor of combination therapies involving a biostatic and a biocidal antimicro-
bial. Note however that the combined drugs need to be chosen carefully, because some of them have antagonistic
interactions [72], depending on their mode of action.
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1 Population with a single type of microorganisms
1.1 Master equation
Let us first consider the simple case of a microbial population with a carrying capacity K comprising a single type
of microorganisms. These microorganisms have a fitness and a death rate denoted by f and g, respectively. Let j
be the number of individuals in the population at time t, satisfying 0 ≤ j ≤ K. The master equation describing
the evolution of this population reads for all j:
dPj(t)
dt
= f
(
1−
j − 1
K
)
(j − 1)Pj−1(t) + g(j + 1)Pj+1(t)−
(
f
(
1−
j
K
)
+ g
)
jPj(t) . (S1)
Indeed, recall that f(1 − j/K) is the division rate in the logistic model. We can write this system of equations as
P˙ = RP, where R is the transition rate matrix:
d
dt

P0
P1
P2
...
PK
 =

0 g 0 · · · 0
0 −g − f(1− 1/K) 2g (0)
...
0 f(1− 1/K) −2g − 2f(1− 2/K)
. . . 0
... (0)
. . .
. . . Kg
0 · · · 0 f(1− (K − 1)/K)(K − 1) −Kg


P0
P1
P2
...
PK
 . (S2)
This Markov chain has a single absorbing state, namely j = 0, which corresponds to the extinction of the microbial
population.
1.2 Average spontaneous extinction time
Let us study the average time it takes for the population to spontaneously go extinct, i.e. the mean first-passage
time τS(j0) to the absorbing state j = 0, starting from j0 microorganisms at t = 0. It can be expressed using
the inverse of the reduced transition rate matrix R˜, which is identical to R except that the row and the column
corresponding to the absorbing state j = 0 are removed [33, 42]:
τS(j0) = E[τ̂FP | j0] = −
K∑
i=1
(R˜−1)i j0 . (S3)
Note that more generally, all the moments of the first-passage time can be obtained using the reduced transition
rate matrix R˜:
E[τ̂nFP | j0] = n!(−1)
n
K∑
i=1
(R˜−n)i j0 . (S4)
Here, the elements of the inverse of the reduced transition matrix read for all 1 ≤ j ≤ K,
(R˜−1)i j =

−
i−1∑
k=0
(
f
g
)i−k−1
Kk+1−i(K − k − 1)!
i g (K − i)!
if i ≤ j ,
−
j−1∑
k=0
(
f
g
)i−k−1
Kk+1−i(K − k − 1)!
i g (K − i)!
if i > j .
(S5)
Substituting Eq. S5 in Eq. S3 yields
τS(j0) =
1
g
 j0∑
i=1
i−1∑
k=0
(
f
g
)i−k−1
Kk+1−i(K − k − 1)!
i (K − i)!
+
K∑
i=j0+1
j0−1∑
k=0
(
f
g
)i−k−1
Kk+1−i(K − k − 1)!
i (K − i)!
 . (S6)
If f = 0, e.g. in the presence of a biostatic antimicrobial that perfectly prevents all microorganisms from growing,
Eq. S6 simplifies to:
τS(j0) =
1
g
j0∑
i=1
1
i
. (S7)
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Note the formal analogy between Eq. S7 and the unconditional fixation time with biostatic antimicrobial (f = 0) in
the Moran process, which corresponds to the extinction of the sensitive microbes in a population of fixed size [33].
Both situations involve the extinction of microorganisms that do not grow. Formally, the master equation of a
Moran process describing a microbial population of fixed size N with two types of individuals A and B whose
respective fitnesses are fA = 0 and fB = 1, reads:
dPl(t)
dt
=
l+ 1
N
Pl+1(t)−
l
N
Pl(t) , (S8)
where l denotes the number of A individuals. The master equation for a logistic growth of a population with a
single type of individuals (see Eq. S1) with f = 0 is equivalent under the transformation 1/N ← g.
Fig. S1 shows how τS(10) depends on the death rate g and the carrying capacity K. In particular, it shows
that when g < f , average extinction times become very long for large values of K, while they are short for all K
when g > f . In a deterministic description (valid for very large population sizes), g = f indeed corresponds to the
transition between a population that decays exponentially and a population that reaches a steady state size. For
finite-sized populations, stochasticity makes this transition smoother.
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Fig S1. Average spontaneous extinction time of the microbial population. A: Mean first-passage time
τS(10) to the absorbing state j = 0, i.e. average extinction time, starting from j0 = 10 microorganisms, as a
function of the fitness f for different carrying capacities K, with g = 0.1. B: Average extinction time τS(10) as a
function of the carrying capacity K for different fitnesses f , with g = 0.1. C: Average extinction time τS(10) as a
function of the death rate g for different carrying capacities K, with f = 1. D: Average extinction time τS(10) as
a function of the carrying capacity K for different death rates g, with f = 1.
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1.3 Initial growth of the population
1.3.1 Deterministic approximation and rise time
In the deterministic regime, for a population with only one type of microorganisms and a carrying capacity K, the
number N of individuals at time t follows the logistic ordinary differential equation:
dN(t)
dt
= N(t)
[
f
(
1−
N(t)
K
)
− g
]
, (S9)
where f represents fitness and g death rate. For f 6= g, the solution reads:
N(t) =
KN0 e
(f−g)t (1− g/f)
K (1− g/f) +N0 (e(f−g)t − 1)
, (S10)
where N0 = N(0) is the initial number of individuals in the population. Note that we recover the usual law of
logistic population growth for f > 0 and g = 0 (or for f > g by setting f ← f − g):
N(t) =
KN0 e
f t
K +N0 (ef t − 1)
. (S11)
For f > g, the long-time limit of Eq. S10 is K(1− g/f). This equilibrium population size can also be found as the
steady-state solution of Eq. S9, and corresponds to the birth and death rates being equal. The rise time tr(α), at
which a fraction α of this equilibrium population size is reached, is given by:
tr(α) =
1
f − g
ln
(
αK(1− g/f)− αN0
(1− α)N0
)
. (S12)
Hence, the initial growth of the population is governed by the timescale 1/(f−g), and features a weaker dependence
on carrying capacity K and initial population size N0, as illustrated by Fig. S2.
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N0 for different carrying capacities K. Results are obtained from Eqs. S10 and S12. Parameter values: f = 1 and
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1.3.2 Probability of rapid initial extinction
A microbial population starting with few individuals may go extinct quickly due to stochastic fluctuations, before
reaching a substantial fraction of its equilibrium size K(1 − g/f). Formally integrating the master equation P˙ =
RP with the initial condition j = j0 allows to express the probability P0(t) that a population starting from j0
microorganisms at t = 0 is extinct at time t:
P0(t) = (e
Rt)0j0 . (S13)
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Fig. S3 shows the probability P0(tr) that the microbial population goes extinct before the rise time tr versus g for
f = 1. We notice that P0(tr) ∼ g/f for small g and/or large K. This result can be proved analytically by assuming
that the number of individuals is very small compared to the carrying capacity K and thus grows exponentially,
which is relevant when rapid initial extinctions occur. One can then neglect the impact of the carrying capacity K
in the master equation Eq. S1, yielding:
dPj(t)
dt
= f(j − 1)Pj−1(t) + g(j + 1)Pj+1(t)− (f + g) jPj(t) . (S14)
The solution of this master equation is given by [73]:
Pj(t) = e
(f−g)t
(
1− g/f
e(f−g)t − g/f
)2(
e(f−g)t − 1
e(f−g)t − g/f
)j−1
. (S15)
In particular, we thus obtain:
P0(t) =
g
f
(
e(f−g)t − 1
e(f−g)t − g/f
)
→
t→+∞
g
f
if f > g . (S16)
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Fig S3. Rapid initial extinction. A: Probability P0(tr) that extinction occurs before the rise time tr(0.99)
(see Eq. S12), when starting from a single microorganism, j0 = 1, as function of the death rate g with f = 1 for
different carrying capacities K. Results come from a numerical computation of Eq. S13. Solid black line: g/f . B:
Probability of rapid initial extinction P0(100) as a function of the initial number of microorganisms j0, for
different carrying capacities K. Data points correspond to numerical computations of Eq. S13. Parameter values:
fS = 1 and gS = 0.1. Time t = 100 was chosen to evaluate P0 because it is larger than typical rise times for the
parameter values considered (see Fig. S2), but not too long, and thus captures rapid initial extinctions but not
long-term ones (see Fig. S1).
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2 Supplementary results on extinction probabilities and extinction
and fixation times
2.1 Perfect biostatic antimicrobial
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Fig S4. Periodic presence of a biostatic antimicrobial that fully stops growth, including long
periods. A: Probability p0 that the microbial population goes extinct before resistance gets established versus
alternation period T , for various carrying capacities K. Markers: simulation results, with probabilities estimated
over 102 − 103 realizations. Horizontal solid colored lines: analytical predictions from Eq. 1. Horizontal solid black
line: average spontaneous valley crossing time τV = (fS − fR)/(µ1µ2gS) (see main text). B: Average time text to
extinction versus alternation period T for various carrying capacities K. Data shown if extinction occurred in at
least 10 realizations. C: Average time tfix to fixation of the C microorganisms versus alternation period T for
various carrying capacities K. Data shown if resistance took over in at least 10 realizations. Horizontal solid lines:
analytical predictions for very small T , using the self-averaged fitness f˜S (see main text). In panels B and C,
markers are averages over 102 − 103 simulation realizations, error bars (often smaller than markers) represent 95%
confidence intervals, and the oblique black line corresponds to T/2. In all panels, colored dashed lines correspond
to T/2 = τS , while black dashed lines correspond to T/2 = τV . Parameter values: fS = 1 without antimicrobial,
f ′S = 0 with antimicrobial, fR = 0.9, fC = 1, gS = gR = gC = 0.1, µ1 = 10
−5 and µ2 = 10
−3. All simulations start
with 10 S microorganisms.
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2.2 Biocidal antimicrobial
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Fig S5. Periodic presence of a biocidal antimicrobial above the MIC, including long periods. A:
Probability p0 that the microbial population goes extinct before resistance gets established versus alternation
period T , for various carrying capacities K. Markers: simulation results, with probabilities estimated over
102 − 103 realizations. Horizontal solid lines: analytical predictions from Eq. 4. B: Average time text to extinction
versus alternation period T for various carrying capacities K. Data shown if extinction occurred in at least 10
realizations. C: Average time tfix to fixation of the C microorganisms versus alternation period T for various
carrying capacities K. Data shown if resistance took over in at least 10 realizations. Horizontal solid colored lines:
analytical predictions for very small T , using the self-averaged death rate g˜S (see below). Horizontal solid black
line: average spontaneous valley crossing time τV = (fS − fR)/(µ1µ2gS) (see main text). In panels B and C,
markers are averages over 102 − 103 simulation realizations, error bars (often smaller than markers) represent 95%
confidence intervals, and the oblique black line corresponds to T/2. In all panels, colored dashed lines correspond
to T/2 = τS , while black dashed lines correspond to T/2 = τV . Parameter values: fS = 1, fR = 0.9, fC = 1,
gS = 0.1 without antimicrobial, g
′
S = 1.1 with antimicrobial, gR = gC = 0.1, µ1 = 10
−5 and µ2 = 10
−3. All
simulations start with 10 S microorganisms.
Here, in the limit of very fast alternations, we expect an effective averaging of death rates, with g˜S = 0.6
for S microorganisms. Then, an R mutant that will fix in the population appears after an average time t˜aR =
1/(N˜µ1g˜Sp˜SR) where N˜µ1g˜S represents the total mutation rate in the population, with N˜ = K(1 − g˜S/fS) the
equilibrium population size, and where p˜SR = [1 − fSgR/(fRg˜S)]/[1 − (fSgR/(fRg˜S))N˜ ] is the probability that a
single R mutant fixes in a population of N˜ microorganisms where all other microorganisms are S. Subsequently, C
mutants will appear and fix, thus leading to the full evolution of resistance by the population. The corresponding
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average total time tfix of resistance evolution [33] agrees well with simulation results for T/2≪ τS (see Fig. S5C).
2.3 Population size dependence of the extinction transition
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Fig S6. Finite size effect on the extinction transition. Value of the ratio R = (g′S − f
′
S)/g
′
S such that
taR = τS , plotted versus the carrying capacity K. This value of R marks the transition between large and small
extinction probability p0 when T/2 > τS (see main text and Fig. 5). Red markers: numerical solutions of the
equation taR = τS . Black dashed line: expected transition in the large population limit (R = 0, i.e. f
′
S = g
′
S).
Parameter values: µ1 = 10
−5, fS = 1, fR = 0.9, gS = gR = 0.1. Here, results are shown in the biostatic case, and
f ′S was varied, keeping g
′
S = 0.1, but the biocidal case yields the exact same results (see main text).
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3 Rescue by resistance
3.1 Number of resistant mutants when antimicrobial is added: pc
R
(i)
Let pcR(i) be the probability that exactly i R microorganisms are present when antimicrobial is added, provided
that a lineage of R mutants then exists. It can be calculated in the framework of the Moran model, provided that
the population size is stable around N = K(1− gS/fS) before antimicrobial is added, which is correct for T/2≫ tr,
where tr is the rise time (see section 1.3.1). Specifically, p
c
R(i) can be expressed as a ratio of the sojourn time in
state i to the total lifetime of the lineage in the absence of antimicrobial:
pcR(i) =
τdR,i
τdR
, (S17)
where τdR is the average lifetime without antimicrobial of the lineage of a resistant mutant, assuming that it is
destined for extinction, and τdR,i is the average time this lineage spends with exactly i R individuals before going
extinct. They satisfy τdR =
∑N−1
i=1 τ
d
R,i. Note that we consider lineages destined for extinction in the absence of
antimicrobial, because we focus on timescales much shorter than the spontaneous valley crossing time. In fact, in
this regime, considering unconditional times yields nearly identical values for pcR(i).
Employing the master equation P˙ = RP that describes the time evolution of the number of R mutants within
the Moran model [13, 33], where R is the transition rate matrix, we obtain
τdR,i =
πi
π1
∫
∞
0
Pi(t)dt = −
πi
π1
(R˜−1)i 1 , (S18)
where πi is the probability that the R mutants go extinct, starting from i R mutants [13,33], while R˜ is the reduced
transition rate matrix, which is identical to the transition rate matrix R, except that the rows and the columns
corresponding to the absorbing states i = 0 and i = N are removed [33]. Here, we take N = K(1− gS/fS), which
corresponds to the deterministic equilibrium population size. Finally, we obtain
pcR(i) =
πi(R˜
−1)i 1∑N−1
k=1 πk(R˜
−1)k 1
. (S19)
3.2 Probability of fast extinction of the resistant mutants: pe
R
(i)
Let us consider the beginning of the first phase with antimicrobial, and take as our origin of time t = 0 the beginning
of the phase with antimicrobial. Here, we consider the general case of an antimicrobial that may modify both the
division rate and the death rate of sensitive microorganisms. Provided that some resistant microorganisms are
present at t = 0, how likely is it that they will undergo a rapid stochastic extinction and not rescue the microbial
population and lead to the establishment of resistance? Denoting by i > 0 the number of resistant microorganisms
at t = 0, let us estimate the probability peR(i) that the lineage of R mutants then quickly goes extinct. As explained
in the main text, we approximate the reproduction rate of the R microorganisms by
fR(t) = fR
(
1−
S(t) +R(t)
K
)
≈ fR
(
1−
S(t)
K
)
, (S20)
where S(t) and R(t) are the numbers of S and R individuals at time t. This is appropriate because early extinctions
of R mutants tend to happen shortly after the addition of antimicrobials, when S(t) ≫ R(t). Thus motivated, we
further employ the deterministic approximation to describe the decreasing number S(t) of S microorganisms:
S(t) =
K(1− g′S/f
′
S)S0e
(f ′
S
−g′
S
)t
K(1− g′S/f
′
S) + S0(e
(f ′
S
−g′
S
)t − 1)
, (S21)
where S0 = K(1 − gS/fS) is the number of sensitive microorganisms when antimicrobial is added. Note that if
f ′S = 0 and g
′
S = gS , i.e. in the perfect biostatic case, we obtain
S(t) = K
(
1−
gS
fS
)
e−gSt , (S22)
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for the decay of the number of S microorganisms with antimicrobial. However, we retain a stochastic description
for the rare R mutants, and employ the probability generating function
φi(z, t) =
∞∑
j=0
zjP (j, t|i, 0) , (S23)
where i is the initial number of R microorganisms. Indeed, noticing that
peR(i) = lim
t→∞
P (0, t|i, 0) = lim
t→∞
φi(0, t) (S24)
will enable us to calculate peR(i) [38, 39].
The probability P (j, t|i, 0) of having j R mutants at time t, starting from i R mutants at time t = 0, satisfies
the master equation
∂P (j, t|i, 0)
∂t
= fR(t) (j − 1)P (j − 1, t|i, 0) + gR (j + 1)P (j + 1, t|i, 0)− (fR(t) + gR) j P (j, t|i, 0) . (S25)
Here, we neglect mutants that appear after the addition of antimicrobial, and we deal with them in the calculation
of paR and p
e′
R . The generating function defined in Eq. S23 satisfies the partial differential equation
∂φi(z, t)
∂t
− (z − 1)(fR(t)z − gR)
∂φi(z, t)
∂z
= 0 . (S26)
This first-order nonlinear partial differential equation can be solved using the method of characteristics. For this,
we rewrite it as:
~v.~∇φi = 0 , (S27)
where ~v = (1, −(z − 1)(fB(t)z − gB))t and ~∇φi = (∂φi/∂t, ∂φi/∂z)t. A characteristic curve ~r(s) satisfies d~r/ds =
~v(~r(s)), which entails
dφi
ds
=
d~r
ds
.~∇φi = ~v.~∇φi = 0 , (S28)
implying that φi is constant along a characteristic curve. Since dφi/ds = (∂φi/∂t)(dt/ds) + (∂φi/∂z)(dz/ds), we
obtain the following system of ordinary differential equations along a characteristic curve:{
dt
ds
= 1 ,
dz
ds
= −(z − 1)(fR(t)z − gR) .
(S29)
We choose to integrate it as {
t = s ,
dz
dt
= −(z − 1)(fR(t)z − gR) .
(S30)
The second ordinary differential equation can be solved by introducing y = 1/(z − 1), which yields
eρ(t)
z − 1
−
∫ t
0
fR(u)e
ρ(u)du =
1
z0 − 1
, (S31)
with
ρ(t) =
∫ t
0
(gR − fR(u)) du , (S32)
where we have employed Eqs. S20 and S22. Eq. S31 is the equation of the characteristic line going through the
point (0, z0). Because φi is constant along this line (see Eq. S28), we have φi(z, t) = φi(z0, 0) = z
i
0 along this line,
where we have used Eq. S23. Furthermore, for any (z, t) we can find the appropriate z0 using Eq. S31. This yields
the following expression for the generating function:
φi(z, t) =
[
1 +
(
eρ(t)
z − 1
−
∫ t
0
fR(u)e
ρ(u)du
)−1]i
, (S33)
where ρ(t) is given by Eq. S32 and fR(t) by Eq. S20.
We can now express the probability peR(i) from Eqs. S24 and S33:
peR(i) = lim
t→∞
[
gR
∫ t
0 e
ρ(u)du
1 + gR
∫ t
0 e
ρ(u)du
]i
. (S34)
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3.3 Predicting the extinction probability p0
Here, we test the analytical predictions for each term involved in the extinction probability p0 of the population
above the MIC, both in the perfect biostatic case (see Eq. 1) and in the biocidal case (see Eq. 4), by comparing
them to numerical simulation results. To estimate the probability pR that at least one R mutant is present when
antimicrobial is added, and to study the number of R mutants that are then present (Fig. S7A-B), simulations
are run starting from j0 = 10 S microorganisms (and no R) as in the rest of our work. We let the population
evolve until a specific time, in practice t = 500, when population size is well-equilibrated around the deterministic
stationary value K(1 − gS/fS) without antimicrobial, and we analyze population composition at this time. To
estimate the probability peR of rapid extinction of the R lineage (Figs. S7C and S9A), we start from a population
with i R microorganisms and K(1 − gS/fS) − i sensitive microorganisms, and we let it evolve with antimicrobial
until extinction of the S microorganisms. All these simulations are run with 2 types of microorganisms, S and R
(no compensation). In Figs. S7C and S9A, we note that peR does not seem to depend on K. In fact, our analytical
estimate for peR is fully independent of K because it only involves the ratio S(t)/K (see Eqs. S34, S32 and S20),
whose deterministic dynamics is independent of K (see Eq. S9 with N(t)← S(t)).
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Fig S7. Perfect biostatic antimicrobial: test of analytical predictions for each term involved in p0
(Eq. 1). A: Probability pR that at least one R mutant is present when antimicrobial is added, plotted versus
carrying capacity K. Markers: simulation results, with probabilities estimated over 104 realizations. Red solid
line: analytical prediction, pR = t
app
R /τ
d
R = Nµ1gSτ
d
R (see main text). B: Probability p
c
R that exactly i R
microorganisms are present when antimicrobial is added, provided that at least one R mutant is present, plotted
versus the number i of R mutants, for various carrying capacities K. Markers: simulation results, estimated over
104 realizations. Solid lines: analytical prediction in Eq. S19. Analytical prediction lines for K = 104 and K = 105
are confounded; note that the prediction holds in the weak mutation regime Kµ1 ≪ 1, and thus fails for K = 105
here. C: Probability peR of rapid extinction of the R lineage, plotted versus the number i of R mutants present
when adding antimicrobial, for various different carrying capacities K. Markers: simulation results, with
probabilities estimated over 104 realizations. Black solid line: analytical prediction from Eq. 2 (see main text).
Parameter values: fS = 1 without antimicrobial, f
′
S = 0 with antimicrobial, fR = 0.9, gS = gR = 0.1 and
µ1 = 10
−5 (A-B) or µ1 = 0 (C).
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The probability paR that resistance appears in the presence of antimicrobial involves the number of divisions
Ndiv and the mean time to extinction τS of a population of S microorganisms in the presence of antimicrobial
(see main text). To estimate these two intermediate quantities, simulations only involving S microorganisms in the
presence of antimicrobial, starting from K(1−gS/fS) sensitive microorganisms, are performed (Fig. S8A-B). For paR
itself (Fig. S9B), simulations with S and R microbes (no compensation), also starting from K(1− gS/fS) sensitive
microorganisms in the presence of antimicrobial, are performed. The time of appearance of R mutants (Fig. S8C-D)
and the number of different lineages that appear during the decay of this population (Fig. S9C) are also studied.
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Fig S8. Biocidal antimicrobial: test of analytical predictions for intermediate quantities involved in
the calculation of p0 (see Eq. 4). A: Average time τS to extinction of a population of S microorganisms in the
presence of antimicrobial, plotted versus the carrying capacity K. Markers: simulation results, with probabilities
estimated over 104 realizations. Red solid line: analytical prediction from Eq. S6, with j0 = K(1− gS/fS). B:
Number Ndiv of individual division events that occur between the addition of antimicrobial and the extinction of
the population of S microorganisms, plotted versus carrying capacity K. Red markers: simulation results, with
probabilities estimated over 104 realizations. Red solid line: analytical prediction from Eq. 5. C and D:
Probability density function ℘aR(t) of the time t of appearance of an R mutant, under the assumption that exactly
one R mutant appears between the addition of antimicrobial and the extinction of the population of S
microorganisms, for K = 103 (C) and K = 104 (D). Histograms: simulation results, with 103 realizations. Black
solid lines: analytical prediction from Eq. 9. Parameter values: fS = 1, gS = 0.1 without antimicrobial, g
′
S = 1.1
with antimicrobial, and in panels C and D, fR = 0.9, gR = 0.1 and µ1 = 10
−5.
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Fig S9. Biocidal antimicrobial: test of analytical predictions for each term involved in p0 (see
Eq. 4). Note that pR and p
c
R are the same as in Fig. S7A-B. A: Probability p
e
R of rapid extinction of the R
lineage, plotted versus the number i of R mutants present when adding antimicrobial, for various different
carrying capacities K. Markers: simulation results, with probabilities estimated over 104 realizations. Black solid
line: analytical prediction from Eq. S34. B: Probability paR that resistance appears in the presence of
antimicrobial, plotted versus the carrying capacity K. Red markers: simulation results, with probabilities
estimated over 104 realizations. Red solid line: analytical prediction, paR = Ndivµ1 with Ndiv in Eq. 5. C:
Probability that i distinct lineages of R mutants appear in the presence of antimicrobial, provided that at least
one appears, plotted versus the carrying capacity K. Markers: simulation results, with probabilities estimated
over 103 realizations. Parameter values: fS = 1, fR = 0.9, gS = 0.1 without antimicrobial, g
′
S = 1.1 with
antimicrobial, gR = 0.1 and µ1 = 0 (panel A) or µ1 = 10
−5 (panels B and C).
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3.4 A perfect biostatic antimicrobial yields a larger p0 than a perfect biocidal antimi-
crobial
For a perfect biostatic antimicrobial, the extinction probability p0 upon the first addition of drug is given by Eq. 1:
p0 = 1− pR
N−1∑
i=1
pcR(i)(1− p
e
R(i)) , (S35)
while for a biocidal antimicrobial, the extinction probability p˜0 upon the first addition of drug is given by Eq. 4:
p˜0 =
[
1− pR
N−1∑
i=1
pcR(i)(1 − p˜
e
R(i))
] [
1− paR(1 − p
e′
R)
]
< 1− pR
N−1∑
i=1
pcR(i)(1− p˜
e
R(i)) . (S36)
In Eq. S36 we have employed tilde symbols to denote the quantities that differ compared to Eq. S35. Recall that
pR and p
c
R(i) are the same in both cases. Indeed, these quantities characterize the state of the population when the
antimicrobial is added, and thus do not depend on the type of treatment subsequently added.
The perfect biocidal antimicrobial corresponds to g′S →∞. Let us prove that limg′S→∞ p˜0 < p0. From Eqs. S35
and S36 it is apparent that it suffices to prove that limg′
S
→∞ p˜
e
R(i) < p
e
R(i) for all i. The expression of both p
e
R(i)
and p˜eR(i) is given in Eq. S34, but it involves the decaying number S(t) of S microorganisms once antimicrobial is
added, which is different in these two cases, and is given respectively by Eq. S21 with f ′S = fS in the biocidal case
and by Eq. S22 in the perfect biostatic case.
Taking the limit g′S → ∞ in Eq. S34 yields limg′S→∞ p˜
e
R(i) = (gR/fR)
i, which corresponds to the extinction
probability of a population that starts from i R microorganisms, in the absence of any other microorganisms [18].
But for a perfect biostatic antimicrobial,
ρ(t) =
∫ t
0
[
gR − fR
(
1−
S(u)
K
)]
du >
∫ t
0
[gR − fR] du = (gR − fR)t , (S37)
which, using Eq. S34, entails that peR(i) > (gR/fR)
i, i.e. limg′
S
→∞ p˜
e
R(i) < p
e
R(i) for all i. Therefore, we have shown
that limg′
S
→∞ p˜0 < p0: the extinction probability p0 is larger for a perfect biostatic antimicrobial than for a perfect
biocidal antimicrobial.
Importantly, our proof does not rely on the appearance of resistant microorganisms while antimicrobial is present,
which cannot happen with a perfect biostatic antimicrobial, and whose probability tends to zero when g′S →∞ with
a biocidal antimicrobial. What makes the perfect biostatic antimicrobial more efficient than the perfect biocidal
one is that S microorganisms survive for a longer time, thereby reducing the division rate of R microorganisms due
to the logistic term, and favoring their extinction. Such a competition effect is realistic if S microorganisms still
take up resources (e.g. nutrients) even while they are not dividing.
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4 Fixation probability of a mutant in a population of constant size
In the main text, in our discussion of sub-MIC concentrations of antimicrobials, we employed the fixation probability
pSR of an R mutant in a population of S individuals with fixed size N :
pSR =
1− fSgR/(fRgS)
1− [fSgR/(fRgS)]N
. (S38)
Here, we briefly justify this formula.
Consider a birth-death process in which, at each discrete time step, one individual is chosen with a probability
proportional to its fitness to reproduce and another one is chosen with a probability proportional to its death
rate to die. Note that at each time step, the total number of individuals in the population stays constant. This
model is a variant of the Moran model with selection both on division and on death. Let i be the number of R
microorganisms and N − i the number of S microorganisms. At a given time step, the probability T+i that the
number of R individuals increases from i to i+ 1 satisfies:
T+i =
fRi
fRi+ fS(N − i)
gS(N − i)
gRi+ gS(N − i)
, (S39)
and similarly, the probability T−i that i decreases by 1 is given by:
T−i =
fS(N − i)
fRi+ fS(N − i)
gRi
gRi+ gS(N − i)
. (S40)
The probability pSR that the R genotype fixes in the population, starting from 1 R microorganism, then satisfies [47]:
pSR =
1
1 +
∑N−1
k=1
∏k
j=1 γj
, (S41)
where
γi =
T−i
T+i
=
fSgR
fRgS
. (S42)
We thus obtain the result announced in Eq. S38.
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5 Detailed simulation methods
In this work, the evolution of microbial populations are simulated using a Gillespie algorithm [40,41]. Let us denote
by jS , jR and jC the respective numbers of S, R and C individuals. The elementary events that can happen are
division with or without mutation and death of an individual microbe of either type:
• S
k
+
S−−→ 2S: Reproduction without mutation of a sensitive microbe with rate k+S = f
e
S(1−(jS+jR+jC)/K)(1−
µ1), with f
e
S = fS if no antimicrobial is present in the environment or f
e
S = f
′
S if antimicrobial is present in
the environment.
• S
kSR−−→ S+R: Reproduction with mutation of a sensitive microbe with rate kSR = feS(1−(jS+jR+jC)/K)µ1.
• S
k−
S−−→ ∅: Death of a sensitive microbe with rate k−S = g
e
S , with g
e
S = gS if no antimicrobial is present in the
environment or geS = g
′
S if antimicrobial is present in the environment.
• R
k
+
R−−→ 2R: Reproduction without mutation of a resistant microbe with rate k+R = fR(1−(jS+jR+jC)/K)(1−
µ2).
• R
kRC−−−→ R+C: Reproduction with mutation of a resistant microbe with rate kRC = fR(1−(jS+jR+jC)/K)µ2.
• R
k
−
R−−→ ∅: Death of a resistant microbe with rate k−R = gR.
• C
k
+
C−−→ 2C: Reproduction of a resistant-compensated microbe with rate k+C = fC(1− (jS + jR + jC)/K).
• C
k
−
C−−→ ∅: Death of a resistant-compensated microbe with rate k−C = gC .
The total rate of events is given by ktot = (k
+
S + kSR + k
−
S )jS + (k
+
R + kRC + k
−
R)jR + (k
+
C + k
−
C )jC .
Simulation steps are as follows:
1. Initialization: The microbial population starts from jS = 10 sensitive microorganisms, jR = 0 resistant
mutant and jC = 0 resistant-compensated mutant at time t = 0 without antimicrobial. The next time when
the environment changes is stored in the variable tswitch, which is initialized at tswitch = T/2, the first time
when antimicrobial is added.
2. The time increment ∆t is sampled randomly from an exponential distribution with mean 1/ktot, and the next
event that may occur is chosen randomly, proportionally to its probability k/ktot, where k is its rate. For
instance, division of a sensitive microorganism without mutation is chosen with probability k+S jS/ktot.
3. If t+∆t < tswitch, time is increased to t+∆t and the event chosen at Step 2 is executed.
4. If t+∆t ≥ tswitch, the event chosen at Step 2 is not executed, because an environment change has to occur
before. The environment change is performed: time is incremented to t = tswitch, and the fitness and death
rate of the sensitive microbes are switched from fS to f
′
S and from gS to g
′
S or vice-versa. In addition, tswitch
is incremented to tswitch + T/2, and thus stores the next time when the environment changes.
5. We go back to Step 2 and iterate until the total number of microbes is zero (jS + jR + jC = 0) or there are
only resistant-compensated mutants (jS = 0, jR = 0 and jC 6= 0).
Note that Step 4 introduces an artificial discretization of time, because environment changes occur at fixed
times and not with a fixed rate. However, because the total event rate is large unless the population size is very
small, the “jump” in time induced by Step 4 is usually extremely small, and the discarded events constitute a tiny
minority of events. The resulting error is thus expected to be negligible. The very good agreement between our
simulation results and our analytical predictions, in particular for short periods, corroborates this point.
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